宫颈癌
- 工具分子
-
- 缺氧标志物
- Pimonidazole
- 获批药物
- Bevacizumab
- Bleomycin sulfate
- Topotecan HCl
- Pembrolizumab
- Tisotumab vedotin
- NCCN指南推荐 [1]
- 化疗方案
-
- CARBOPLATIN-TAXOL
- Carboplatin
- Paclitaxel
-
- GEMCITABINE-CISPLATIN
- Gemcitabine HCl
- Cisplatin
- 抗病毒感染
- 免疫检查点抑制剂
- 抗血管生成 [2]
-
- Angiotensin
- Angiotensin II human Acetate
- Angiotensin
- Azilsartan
- Olmesartan
- 靶向疗法 (A) [3]
-
- CD44
- Bivatuzumab
- Angstrom6
-
- ALDH
- Disulfiram
- Daidzin
- NCT-501
- Alda 1
- CM10
-
- NANOG
- Amcasertib
- 靶向疗法 (B) [3]
-
- LGR5
- Petosemtamab
-
- α-SMA
- CCG-222740
- Apamin
-
- Vimentin
- Withaferin A
-
- KLF4
- APTO-253
-
- β-catenin
- IWP-2
- Laduviglusib
- Capmatinib
- 干细胞标志物 [3]
-
- NANOG
- Amcasertib
-
- KLF4
- APTO-253
-
- CD133
- Amcasertib
-
- Cd44
- Bivatuzumab
- Angstrom6
-
- ALDH1
- Disulfiram
- NCT-501
- CM10
-
- LGR5
- Petosemtamab
- 上皮-间质转化 [3]
-
- Vimentin
- Withaferin A
- 相关化合物库
- FDA-approved Anticancer Drug Library
- Anti-cancer Compound Library
- Anti-cancer Compound Library-Ⅱ
- Anti-cancer Metabolism Compound Library
- Cambridge Cancer Compound Library
- Small Molecule Immuno-Oncology Compound Library
- Angiogenesis Related compound Library
- PI3K/Akt Inhibitor Library
- NF-κB Signaling Compound Library
- Stem Cell Signaling Compound Library
